← Eichor
Study identifier: NCT06526689 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Lung Innate Immunity and Microbiome After Tuberculosis Exposure

Condition: Tuberculosis · Latent Tuberculosis  ·  Sponsor: University of Oxford

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

To characterise the innate pulmonary immune response and respiratory microbiome after recent exposure to M.tb and to evaluate how differences determine the outcome of M.tb exposure

This description comes directly from the study's public registry record.

Talk to the study team

Timothy Fredsgaard-Jones, MBBS  ·  +44 (0)1865 611385  ·  timothy.fredsgaard-jones@ndm.ox.ac.uk

Always discuss trial participation with your own doctor first.

Locations (3)

Churchill HospitalOxford, Oxfordshire, United KingdomRecruiting
Centre for Clinical Vaccinology and Tropical MedicineOxford, Oxon, United KingdomRecruiting
Grove Building, Royal Free NHS Foundation TrustLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06526689